BALLESTRERO, ALBERTO
BALLESTRERO, ALBERTO
100007 - Dipartimento di Medicina interna e specialità mediche
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer
2011-01-01 Soncini, Debora; Caffa, Irene; Zoppoli, Gabriele; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer
2011-01-01 Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1
2017-01-01 Altieri, Paola; Murialdo, Roberto; Barisione, Chiara; Lazzarini, Edoardo; Garibaldi, Silvano; Fabbi, Patrizia; Ruggeri, Clarissa; Borile, Silvia; Carbone, Federico; Armirotti, Andrea; Canepa, Marco; Ballestrero, Alberto; Brunelli, Claudio; Montecucco, Fabrizio; Ameri, Pietro; Spallarossa, Paolo
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia
2008-01-01 Cirmena, Gabriella; Aliano, Stefania; Fugazza, Giuseppina; Bruzzone, Roberto; Garuti, A; Bocciardi, Renata; Bacigalupo, A; Ravazzolo, Roberto; Ballestrero, Alberto; Sessarego, Mario
A modular framework for the development of targeted Covid-19 blood transcript profiling panels
2020-01-01 Rinchai, D.; Syed Ahamed Kabeer, B.; Toufiq, M.; Tatari-Calderone, Z.; Deola, S.; Brummaier, T.; Garand, M.; Branco, R.; Baldwin, N.; Alfaki, M.; Altman, M. C.; Ballestrero, A.; Bassetti, M.; Zoppoli, G.; De Maria, A.; Tang, B.; Bedognetti, D.; Chaussabel, D.
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs.
2012-01-01 Tortolina, Lorenzo; Castagnino, N; De Ambrosi, C; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Parodi, Silvio
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation
2019-01-01 Sparatore, Bianca; Pedrazzi, Marco; Garuti, Anna; Franchi, Alice; Averna, Monica; Ballestrero, Alberto; De Tullio, Roberta
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer.
2012-01-01 Gasparini, G; Torino, F; Ueno, T; Cascinu, S; Troiani, T; Ballestrero, Alberto; Berardi, R; Shishido, J; Yoshizawa, A; Mori, Y; Nagayama, S; Morosini, P; Toi, M.
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib
2010-01-01 Cea, Michele; Cirmena, Gabriella; Garuti, Anna; Rocco, Ilaria; Palermo, Claudia; Cagnetta, Antonia; Moran, Eva; Colombo, Nicoletta; Grasso, Raffaella; Fugazza, Giuseppina; Gobbi, Marco; Nencioni, Alessio; Ballestrero, Alberto; Patrone, Franco
Abstract 2116:CHEK2(Chk2) endogenous activation is associated with p53 deficiency and downregulation ofBRCA2and Fanconi Anemia pathway gene members in the National Cancer Institute Anticancer Tumor Cell Line Panel (NCI-60)
2012-01-01 Zoppoli, Gabriele; Solier, Stéphanie; Reinhold, William C.; Liu, Hongfang; Connelly, John W.; Monks, Anne; Shoemaker, Robert H.; Abaan, Ogan D.; Davis, Sean R.; Piras, Daniela; Ballestrero, Alberto; Meltzer, Paul S.; Doroshow, James H.; Pommier, Yves
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m
2014-01-01 Zoppoli, Gabriele; Garuti, Anna; Rocco, Ilaria; Palermo, Claudia; Cirmena, Gabriella; Carminati, ENRICO GIANNI; Friedman, Daniele; Verdun di Cantogno, Ludovica; Sapino, Anna; Patrone, Franco; Ballestrero, Alberto
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells
2002-01-01 Nencioni, Alessio; Boy, Davide; Rocco, Ilaria; Garuti, Anna; Brugger, W; Wesselborg, S; Patrone, Franco; Ballestrero, Alberto
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial.
2001-01-01 Ballestrero, Alberto; Rubagotti, Alessandra; Stura, P; Ferrando, F; Amoroso, D; Rinaldini, M; Sismondi, P; Genta, F; Mesiti, M; Brema, F; Patrone, Franco; Boccardo, Francesco; GROCTA ITALIAN BREAST CANCER ADJUVANT, Study
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.
2014-01-01 Pedrazzoli, P; Martinelli, G; Gianni, Am; Da Prada, Ga; Ballestrero, Alberto; Rosti, G; Frassineti, Gl; Aieta, M; Secondino, S; Cinieri, S; Fedele, R; Bengala, C; Bregni, M; Grasso, D; De Giorgi, U; Lanza, F; Castagna, L; Bruno, B; Martino, M
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies.
2015-01-01 Tortolina, Lorenzo; Duffy, Dj; Maffei, Massimo; Castagnino, Nicoletta; Carmody, Am; Kolch, W; Kholodenko, Bn; DE AMBROSI, Cristina; Barla, A; Biganzoli, Em; Nencioni, Alessio; Patrone, Franco; Ballestrero, Alberto; Zoppoli, Gabriele; Verri, Alessandro; Parodi, Silvio
Advances in dynamic modeling of colorectal cancer signalingnetwork regions, a path toward targeted therapies
2015-01-01 Tortolina, L.; Duffy, D. J.; Maffei, M.; Castagnino, N.; Carmody, A. M.; Kolch, W.; Kholodenko, B. N.; De Ambrosi, C.; Barla, A.; Biganzoli, E. M.; Nencioni, A.; Patrone, F.; Ballestrero, A.; Zoppoli, G.; Verri, A.; Parodi, S.
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.
2015-01-01 Coco, S; Truini, Anna; Alama, A; Dal Bello, Mg; Venè, R; Garuti, Anna; Carminati, ENRICO GIANNI; Rijavec, E; Genova, Carlo; Barletta, G; Sini, C; Ballestrero, Alberto; Boccardo, Francesco; Grossi, Francesco
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
2011-01-01 Bello, C; Dal Bello, G; Cea, Michele; Nahimana, A; Aubry, D; Garuti, Anna; Motta, Giulia; Moran, Eva; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Zimmermann, K; Loretan, J; Wartmann, M; Duchosal, Ma; Nencioni, Alessio; Vogel, P.
Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates.
1987-01-01 Dallegri, Franco; Frumento, G; Ballestrero, Alberto; Goretti, R; Torresin, A; Patrone, Franco
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS
2009-01-01 Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer | 1-gen-2011 | Soncini, Debora; Caffa, Irene; Zoppoli, Gabriele; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio | |
| 1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer | 1-gen-2011 | Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio | |
| 5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 | 1-gen-2017 | Altieri, Paola; Murialdo, Roberto; Barisione, Chiara; Lazzarini, Edoardo; Garibaldi, Silvano; Fabbi, Patrizia; Ruggeri, Clarissa; Borile, Silvia; Carbone, Federico; Armirotti, Andrea; Canepa, Marco; Ballestrero, Alberto; Brunelli, Claudio; Montecucco, Fabrizio; Ameri, Pietro; Spallarossa, Paolo | |
| A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia | 1-gen-2008 | Cirmena, Gabriella; Aliano, Stefania; Fugazza, Giuseppina; Bruzzone, Roberto; Garuti, A; Bocciardi, Renata; Bacigalupo, A; Ravazzolo, Roberto; Ballestrero, Alberto; Sessarego, Mario | |
| A modular framework for the development of targeted Covid-19 blood transcript profiling panels | 1-gen-2020 | Rinchai, D.; Syed Ahamed Kabeer, B.; Toufiq, M.; Tatari-Calderone, Z.; Deola, S.; Brummaier, T.; Garand, M.; Branco, R.; Baldwin, N.; Alfaki, M.; Altman, M. C.; Ballestrero, A.; Bassetti, M.; Zoppoli, G.; De Maria, A.; Tang, B.; Bedognetti, D.; Chaussabel, D. | |
| A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. | 1-gen-2012 | Tortolina, Lorenzo; Castagnino, N; De Ambrosi, C; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Parodi, Silvio | |
| A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation | 1-gen-2019 | Sparatore, Bianca; Pedrazzi, Marco; Garuti, Anna; Franchi, Alice; Averna, Monica; Ballestrero, Alberto; De Tullio, Roberta | |
| A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. | 1-gen-2012 | Gasparini, G; Torino, F; Ueno, T; Cascinu, S; Troiani, T; Ballestrero, Alberto; Berardi, R; Shishido, J; Yoshizawa, A; Mori, Y; Nagayama, S; Morosini, P; Toi, M. | |
| A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib | 1-gen-2010 | Cea, Michele; Cirmena, Gabriella; Garuti, Anna; Rocco, Ilaria; Palermo, Claudia; Cagnetta, Antonia; Moran, Eva; Colombo, Nicoletta; Grasso, Raffaella; Fugazza, Giuseppina; Gobbi, Marco; Nencioni, Alessio; Ballestrero, Alberto; Patrone, Franco | |
| Abstract 2116:CHEK2(Chk2) endogenous activation is associated with p53 deficiency and downregulation ofBRCA2and Fanconi Anemia pathway gene members in the National Cancer Institute Anticancer Tumor Cell Line Panel (NCI-60) | 1-gen-2012 | Zoppoli, Gabriele; Solier, Stéphanie; Reinhold, William C.; Liu, Hongfang; Connelly, John W.; Monks, Anne; Shoemaker, Robert H.; Abaan, Ogan D.; Davis, Sean R.; Piras, Daniela; Ballestrero, Alberto; Meltzer, Paul S.; Doroshow, James H.; Pommier, Yves | |
| Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m | 1-gen-2014 | Zoppoli, Gabriele; Garuti, Anna; Rocco, Ilaria; Palermo, Claudia; Cirmena, Gabriella; Carminati, ENRICO GIANNI; Friedman, Daniele; Verdun di Cantogno, Ludovica; Sapino, Anna; Patrone, Franco; Ballestrero, Alberto | |
| Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells | 1-gen-2002 | Nencioni, Alessio; Boy, Davide; Rocco, Ilaria; Garuti, Anna; Brugger, W; Wesselborg, S; Patrone, Franco; Ballestrero, Alberto | |
| Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. | 1-gen-2001 | Ballestrero, Alberto; Rubagotti, Alessandra; Stura, P; Ferrando, F; Amoroso, D; Rinaldini, M; Sismondi, P; Genta, F; Mesiti, M; Brema, F; Patrone, Franco; Boccardo, Francesco; GROCTA ITALIAN BREAST CANCER ADJUVANT, Study | |
| Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry. | 1-gen-2014 | Pedrazzoli, P; Martinelli, G; Gianni, Am; Da Prada, Ga; Ballestrero, Alberto; Rosti, G; Frassineti, Gl; Aieta, M; Secondino, S; Cinieri, S; Fedele, R; Bengala, C; Bregni, M; Grasso, D; De Giorgi, U; Lanza, F; Castagna, L; Bruno, B; Martino, M | |
| Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. | 1-gen-2015 | Tortolina, Lorenzo; Duffy, Dj; Maffei, Massimo; Castagnino, Nicoletta; Carmody, Am; Kolch, W; Kholodenko, Bn; DE AMBROSI, Cristina; Barla, A; Biganzoli, Em; Nencioni, Alessio; Patrone, Franco; Ballestrero, Alberto; Zoppoli, Gabriele; Verri, Alessandro; Parodi, Silvio | |
| Advances in dynamic modeling of colorectal cancer signalingnetwork regions, a path toward targeted therapies | 1-gen-2015 | Tortolina, L.; Duffy, D. J.; Maffei, M.; Castagnino, N.; Carmody, A. M.; Kolch, W.; Kholodenko, B. N.; De Ambrosi, C.; Barla, A.; Biganzoli, E. M.; Nencioni, A.; Patrone, F.; Ballestrero, A.; Zoppoli, G.; Verri, A.; Parodi, S. | |
| Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. | 1-gen-2015 | Coco, S; Truini, Anna; Alama, A; Dal Bello, Mg; Venè, R; Garuti, Anna; Carminati, ENRICO GIANNI; Rijavec, E; Genova, Carlo; Barletta, G; Sini, C; Ballestrero, Alberto; Boccardo, Francesco; Grossi, Francesco | |
| Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. | 1-gen-2011 | Bello, C; Dal Bello, G; Cea, Michele; Nahimana, A; Aubry, D; Garuti, Anna; Motta, Giulia; Moran, Eva; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Zimmermann, K; Loretan, J; Wartmann, M; Duchosal, Ma; Nencioni, Alessio; Vogel, P. | |
| Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates. | 1-gen-1987 | Dallegri, Franco; Frumento, G; Ballestrero, Alberto; Goretti, R; Torresin, A; Patrone, Franco | |
| ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS | 1-gen-2009 | Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco |